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Abstract
Background: As n-3 Polyunsaturated Fatty Acids exert a beneficial action on the cardiovascular system, it is important
to investigate their effects on endothelial cell responses that (like migration) contribute to repairing vascular lesions.
Methods: To this purpose, using functional and morphological in vitro assays, we have examined the effect of n-3
Polyunsaturated Fatty Acids on the migration of endothelial cells.
Results: We report here that incubation of endothelial cells with n-3 Polyunsaturated Fatty Acids impaired cell
migration into a wound, triggered peripheral distribution of focal adhesions and caused partial disassembly of actin
filaments. We also found that eicosapentaenoic acid and docosahexaenoic acid exerted similar effects on the focal
adhesions, but that eicosapentaenoic acid was sufficient for inhibiting cell migration.
Conclusions: Given the importance of endothelial cell migration in the repair of vascular injuries, these in vitro
findings call for in vivo evaluation of vascular repair in response to different dietary ratios of eicosapentaenoic to
docosahexaenoic acid.
Background
Dietary intake of n-3 Polyunsaturated Fatty Acids (PUFA)
is perhaps the most favourable lipid-lowering intervention
that is associated with reduced risks of mortality [1]. In
particular, a randomized clinical trial supports their use
after myocardial infarction [2]. In addition, n-3 PUFA
exert a protective action against general diseases that affect
the cardiovascular system, such as obesity and diabetes [1].
Therefore, detailed analysis of the effects of n-3 PUFA on
vascular cells is expected to provide a more rational basis
for their clinical use. However, our understanding of the
effects of n-3 PUFA at the cellular level is far from being
complete.
In this study, we focused on the effect of n-3 PUFA on
endothelial cell (EC) migration, because migration is
essential for vessel formation (e.g.c o l l a t e r a lg r o w t hi n
ischemia) and repair (e.g. endothelial healing upon angio-
plasty). In this respect, the n-3 PUFA eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) are of parti-
cular interest, not only because they are widely used in
cardiovascular medicine [1], but also because they change
the fatty acid composition of the membranes [3] and affect
different types of membrane proteins. In particular, by
modulating the relative phospholipid composition of the
lipid rafts [4,5], n-3 PUFA affect the association of some
signaling proteins with the lipid rafts [6,7].
Furthermore, n-3 PUFA regulate gene expression [8],
modulate eicosanoid activity [3] and exert variable effects
on other signaling pathways, including Akt and Erk-1/2
phosphorylation [9]. Concerning endothelial cells, studies
aimed at explaining the protective action of n-3 PUFA in
atherosclerosis and thrombosis have reported on the abil-
ity of DHA to inhibit endothelial responses to inflamma-
tory cytokines, including the expression of adhesion
molecules involved in leukocyte migration [10] and the
induction of cycloxigenase-2, which ultimately may trigger
NFB activation [11].
Here, we surmised that, in addition to these responses,
PUFA might interfere with other biological processes
that involve membrane proteins, such as cell migration.
Results
Addition of n-3 PUFA increases the membrane content of
EPA and DHA
Incubation of confluent EC (for 24 hours at 37°C) with a
mixture of n-3 PUFA ethyl esters (EE) caused a signifi-
cant increase in the membrane content of total n-3
* Correspondence: gianfranco.bazzoni@marionegri.it
Mario Negri Institute of Pharmacological Research, Via La Masa 19, Milano,
Italy
Tonutti et al. Journal of Angiogenesis Research 2010, 2:12
http://www.jangiogenesis.com/content/2/1/12 JOURNAL OF
ANGIOGENESIS RESEARCH
© 2010 Tonutti et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.PUFA (i.e. the sum of 20:5, 22:5 and 22:6 n-3) and a
slight decrease in monounsaturated fatty acids, while no
changes in n-6 PUFA and saturated fatty acids were
detectable (Fig. 1a). More specifically, the content of
EPA (20:5), its elongation product (22:5) and DHA
(22:6) were all significantly increased compared to vehi-
cle (ethanol)-incubated cells (Fig. 1b). Other n-3 PUFA
(e.g. 18:3 and 20:3) were undetectable in both vehicle-
and n-3 PUFA-incubated cells.
n-3 PUFA inhibit endothelial cell migration
We next examined the effect of n-3 PUFA on endothelial
cell migration. To this purpose, confluent EC monolayers
were scratch wounded and then incubated with medium
(control), ethanol (vehicle) or 100 μM n-3 PUFA EE for
different time points (0, 3, 6 and 24 hours). Finally, the
width of the wound was measured to quantify migration
(Fig. 2a). In control-and vehicle-treated cells, the wound
width was reduced at 6 and 24 hours, compared with the
initial width (at time 0). In contrast, in n-3 PUFA-treated
cells, the width was not reduced, thus indicating that n-3
PUFA impaired migration into the wound (Fig. 2b). Cell
viability, as evaluated by the trypan blue exclusion test,
was not significantly different between cells that had
been treated (for 24 hours) with either vehicle or 100 μM
PUFA EE (79 ± 8% and 76 ± 4% of viable cells,
respectively).
EPA is responsible for the n-3 PUFA effect on cell
migration
The mixture of n-3 PUFA EE, which was used for the
above experiments, contains EPA EE (46.2%), DHA EE
(40.8%) and other fatty acid EE (13.0%). To define which
of the major n-3 PUFA was responsible for the inhibi-
tion of migration, we used purified EPA EE and DHA
EE, either alone or in combination, and then measured
the wound width (Table 1).
As above, at 24 hours, the wound width was reduced
in control- and vehicle (ethanol)-treated cells, but not in
cells treated with the mixture of n-3 PUFA EE. In addi-
tion, we found that the wound width was reduced in
cells treated with DHA EE alone, but not with EPA EE
(either alone or in combination with DHA EE), thus
suggesting that EPA was responsible for the anti-migra-
tory action.
n-3 PUFA-dependent inhibition of migration is MAPK-
independent
Mitogen-Activated Protein Kinases (MAPK) are key regu-
lators of cell migration [12]. In particular, EC migration
into a wound requires ERK-1/2 activation [13]. In agree-
ment with these findings, we observed that migration was
reduced in cells treated with the ERK-1/2 inhibitor
PD098059, compared with control-treated cells (Fig. 3a).
However, when analyzing cells that had been treated in
either the presence or absence of the n-3 PUFA EE mix-
ture, EPA EE and DHA EE (either alone or in combina-
tion, each at 100 μM), we found that none of the
treatments changed the levels of total and active ERK-1/2,
as assessed by Western blotting (not shown). In addition,
the ERK-1/2 activator anandamide neither increased
migration per se nor prevented the n-3 PUFA-dependent
inhibition of migration (Fig. 3b). Anandamide effect was
evaluated at 6 hours, as it was toxic at longer incubation
times.
In addition, we found that the p38/SAPK2 activator
anisomycin induced dose-dependent (2-2,000 nM) inhi-
bition of migration, with half-maximal inhibition at
about 250 nM (Fig. 3c). However, non-inhibitory con-
centrations of n-3 PUFA (10 μM) and anisomycin
(2 nM) did not potentiate each other (Fig. 3d). Thus,
although cell migration was sensitive to either ERK-1/2
inhibition or p38/SAPK2 activation, it is conceivable
that n-3 PUFA did not inhibit migration by regulating
the activation state of these two MAPK.
Figure 1 n-3 PUFA change the relative fatty acid composition
of endothelial membranes. Confluent EC were incubated for 24
hours with either ethanol (vehicle)o r5 0μM n-3 PUFA EE. Then,
membranes were analyzed by chromatography for the composition
of (a) total n-3 PUFA, n-6 PUFA and saturated fatty acids, as well as
(b) the n-3 PUFA 20:5, 22:5 and 22:6. Results are mean ± SD from
three experiments (* p < 0.05).
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with cytoskeletal changes
Fluorescence microscopy revealed morphological differ-
ences in the migrating cells that were facing the wound
(Fig. 4a). Specifically, in control-and vehicle-treated
cells, vinculin-containing focal adhesions (FA) distribu-
ted evenly at the base of the leading lamella, while actin
filaments aligned in parallel to the wound. In contrast,
in n-3 PUFA-treated cells, FA localized to the free cell
edge, actin filaments aligned perpendicular to the
wound, and the number of cells that extended lamella-
like protrusions was reduced.
Similar cytoskeletal changes were detectable in the
confluent cells that were not facing the wound (not
shown) and in non-contacting cells (Fig. 4b). Specifi-
cally, in non-contacting cells incubated with medium or
vehicle, FA evenly distributed throughout the cell, while
actin filaments organized in cortical fibers. In contrast,
upon treatment with n-3 PUFA EE, FA localized almost
exclusively to the cell periphery, while cortical actin was
Figure 2 n-3 PUFA inhibit migration into a wound. Confluent EC were wounded and incubated with medium, vehicle or n-3 PUFA EE. Then,
cells were fixed, stained with FITC-phalloidin and examined by fluorescence microscopy. Representative samples are shown in (a), while the
wound widths are reported in (b) as mean ± SD from three experiments performed in duplicate (** p < 0.01).
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affect microtubule morphology in contacting and non-
contacting cells alike.
We also determined that the fraction of non-contact-
ing cells with peripheral FA was negligible in control-
and vehicle-treated cells (0.0 ± 0.0 and 0.7 ± 1.2%,
respectively), but high (70.0 ± 10.6%) in cells treated
with the mixture of n-3 PUFA EE. A significant fraction
was also detected in cells treated with EPA EE (24.0 ±
11.1%), DHA EE (17.7 ± 5.5%) or the combination of
both EPA and DHA EE (67.0 ± 15.0%). Thus, FA distri-
bution was attributable to the combined action of EPA
and DHA.
Discussion
The major findings of this study are that n-3 PUFA (i)
inhibited migration into a wound and (ii) induced rear-
rangements of migration-related cytoskeletal structures
(i.e. FA and actin filaments). In addition, (iii) while EPA
and DHA exerted similar effects on the FA, EPA was
sufficient for inhibiting migration.
The anti-migratory effect of EPA was not expression
of a nonspecific anti-motility action. Actually, using the
modified Boyden chamber assay, previous studies
reported that EPA (but not DHA) increased EC migra-
tion [14] and rescued the anti-migratory action of cho-
lesterol [15]. These studies are not at odds with the
herein reported inhibitory action of EPA, as the Boyden
Figure 3 Role of MAPK in the n-3 PUFA-dependent inhibition of migration. At 24 hours after plating, EC monolayers were switched to low-
serum (1%) medium and pre-treated with the indicated MAPK regulators for additional 24 hours. Finally, monolayers were wounded and
incubated (in low-serum medium) in either the absence or presence of the indicated compounds for either 6 (b) or 24 (a, c and d) hours. Data
are mean ± SD from three experiments, each performed in duplicate (* p < 0.05; ** p < 0.01, compared with the control treatment at the same
time point, second column bar).
Table 1 Specificity of the n-3 PUFA effect on cell
migration
Treatment Wound width (μm)
Medium 852 ± 15
Vehicle (ethanol) 905 ± 118 ns
PUFA EE 1166 ± 94 **
DHA EE 896 ± 51 ns
EPA EE 1189 ± 60 **
DHA EE + EPA EE 1156 ± 9 **
Confluent EC monolayers were wounded and treated with the indicated
compound (each at a concentration of 100 μM) for 24 hours before being fixed
and inspected by fluorescence microscopy to quantitate the wound width. The
initial width (at time 0) measured 1194 ± 7 μm. Data are means ± SD from
three different experiments (each performed in duplicate). **p < 0.01; ns not
significant (compared with medium).
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Page 4 of 8Figure 4 n-3 PUFA affect FA and actin filaments. In (a), EC were grown to confluence and wounded. In (b), EC were allowed to adhere (as
non-contacting cells) for 2 hours. Then, cells were incubated for 24 hours (a) or 1 hour (b) with medium (control), ethanol (vehicle) and 100 μM
n-3 PUFA EE.
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while the wound assay evaluates the collective migration
of cohesive cell sheets. In addition, our findings mirror
the observation that EPA (but not DHA) inhibited the
ability of EC to form tube-like structures in collagen
gels, which requires coordinated motility and cytoskele-
tal rearrangements of cohesive EC [16].
Published evidence prompted us to evaluate the possible
involvement of the MAPK. In particular, hydrogen perox-
ide-dependent distribution of the FA to the cell periphery
[17] (similar to the one induced by n-3 PUFA) required
p38/SAPK2 activation and/or ERK-1/2 inhibition [18,19].
Notably, also n-3 PUFA were reported to induce and
reduce the activation state of p38/SAPK2 [20] and ERK-1/
2 [21,22], respectively. In line with these observations, we
found that a p38/SAPK2 activator and an ERK-1/2 inhibi-
tor alike impaired EC migration. However, the use of n-3
PUFA and MAPK modulators indicated that the herein
reported effect of the n-3 PUFA on migration was MAPK-
independent. Thus, the molecular identity of the mediator
(s) of n-3 PUFA action deserves further investigation.
Most of our experiments relied on the use of a mixture
of n-3 PUFA EE, which is also used as dietary supple-
ment for laboratory animals, thus allowing comparative
analysis of in vitro and in vivo data. The herein reported
anti-migratory action of n-3 PUFA in vitro has a potential
interest for cardiovascular pharmacology, as it suggests
that n-3 PUFA might delay wound repair in areas of
endothelial damage (e.g. atherosclerotic plaques). In addi-
tion, the impairment in endothelial repair might explain
why dietary supplementation with n-3 PUFA does not
exert significant prevention of atherosclerotic plaque pro-
gression in carotid arteries [23].
However, we also used purified n-3 PUFA EE, which
provided us with further insights. First, the ability of
EPA (20:5), but not DHA (22:6), to inhibit cell migration
suggests that the effect is related to the length of the
carbon chain. Similarly, in T cells, EPA, but not DHA,
inhibited signaling downstream of Src-like tyrosine
kinases, which might be due to differences in the ability
of the two PUFA to incorporate into membrane micro-
domains and to displace these signaling molecules [24].
Thus, it is possible that also the EPA-specific inhibition
of migration is due to specific interactions with the
membrane microdomains. Second, the use of purified
n-3 PUFA EE has allowed us to determine that both
EPA and DHA inhibited FA distribution, but that EPA
was sufficient to inhibit migration. Clearly, although FA
formation is a key step of migration, the process of
migration involves additional responses (e.g. lamellipodia
extension and actin-myosin contraction) that might be
more sensitive to EPA than to DHA.
Other studies have shown differences in the biological
effects of EPA and DHA [25]. In addition to differences
in metabolic and hemodynamic effects (e.g. dyslipidemia
improvement and blood pressure reduction), EPA and
DHA differ in their ability to reduce inflammatory and
thrombotic responses. In particular, emerging evidence
indicates that DHA is more efficient than EPA in inhi-
biting monocyte activation and platelet aggregation. For
instance, DHA (but not EPA) decreased cytokine pro-
duction, the expression of endothelial adhesion mole-
cules and monocyte adhesion to the EC [26]. In
addition, DHA was more effective than EPA in reducing
platelet aggregation and thromboxane release [27].
Thus, together with these findings, our observations
may have practical implications. With all the caveats of
transferring experimental data to the clinical practice,
we suggest that decreasing the dietary supplementation
of EPA might prove beneficial in acute conditions of
vascular damage (e.g. following angioplasty), not only
because DHA is more potent than EPA in inhibiting
platelet aggregation and local inflammation, but also
because (as shown here) DHA does not interfere with
the ability of EC to repair areas of endothelial damage.
Clearly, in vivo assays are necessary to validate the
in vitro effect of n-3 PUFA on wound re-endothelializa-
tion. However, the available in vivo assays, such as arter-
ial injury after balloon angioplasty [28], do not exactly
mirror our in vitro situation. In particular, the most com-
monly documented response to angioplasty is hyperplasia
of the intima [29] and not endothelialization of the
wound. In addition, in the fewer studies that reported
endothelial regeneration, the response was more depen-
dent on the recruitment of bone marrow-derived EC
progenitors than on the migration of EC from the wound
edge [30,31]. Interestingly, our findings are reminiscent
of in vivo effects of n-3 PUFA in the skin excision assay
[32], even though the model is only in part relevant to
the vascular situation. For instance, dogs fed n-3 PUFA-
enriched diet displayed early defects in the epithelial
regeneration of surgical skin wounds [33]. In addition,
dietary supplementation of fish oil n-3 PUFA and topical
application of the n-3 PUFA linolenic acid delayed skin
wound healing in humans [34] and rats [35], respectively.
Finally, besides migration, one should take into account
other effects of the n-3 PUFA on the endothelial cell,
such as the interference with pro-inflammatory and-
atherogenic programs [36], when evaluating at a cellular
level the basis of the beneficial action that the n-3 PUFA
exert on the vascular function and that is documented by
a large body of in vivo and clinical studies.
Conclusions
In conclusion, we have reported here that n-3 PUFA
inhibit EC migration possibly due to their ability to
affect the cytoskeleton. In addition, the observed differ-
ences in efficacy between EPA and DHA highlight the
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practice.
Methods
Cell lines, antibodies and reagents
The endothelial cell line H5V, which was derived from
the murine heart [37], was cultured in D-MEM (Gibco-
BRL) supplemented with 10% fetal bovine serum
(Sigma). Mouse anti-vinculin mAb hVIN-1, mouse anti-
alpha-tubulin mAb B-5-1-2 and FITC-phalloidin were
from Sigma. TRITC-labeled anti-IgG (H+L) anti-mouse
antibody was from Jackson Immuno Research Labora-
tories Inc. The mixture of n-3 PUFA ethyl esters (EE)
was obtained from SPA (Milan), while the esterified
fatty acids EPA and DHA were purchased from Chro-
maDex and Sigma, respectively. Human fibronectin and
the ERK-1/2 inhibitor 2-(2-Amino-3-methoxy-phenyl)-
4H-1-benzopyran-4-one (PD098059) were from Sigma.
The ERK-1/2 activator N-Arachidonoyl-ethanolamine
(anandamide) and the p38/SAPK2 activator 2-(p-Meth-
oxybenzyl)-3,4-pyrrolidinediol-3-acetate (anisomycin)
were from Alexis. Antibodies against p44/42 ERK-1/2
and phospho-ERK-1/2 (pThr202/pTyr204) were from
Cell Signaling Technology.
Fatty acid analysis
Membrane isolation and analysis of their relative fatty
acid composition were performed as described [38].
Briefly, lipids from approximately 2.5 × 10
5 EC were
extracted according to the method of Folch [39]. Then,
aliquots of the chloroform phases containing lipids were
evaporated to dryness. Fatty acid methyl esters in total
lipids were prepared and injected into an Autosystem
XL gas chromatograph (Perkin Elmer) connected with a
flame ionisation detector. Individual fatty acid methyl
esters were identified by comparing their retention
times with corresponding standards (run in parallel),
and their composition was calculated using a Turbo-
chrom system, version 6.1 (Perkin Elmer).
Wound assay
Cells were seeded (at a density of 1.5 × 10
5/cm
2)o n t o
glass cover slips (that had been coated with fibronectin;
7 μg/mL) and grown to confluence. Then, the culture
medium was removed, and scratch wounds were pro-
duced using a plastic tip for 1,000 μL pipettes. After two
washes with D-PBS, cells were incubated with D-MEM
medium containing 10% serum, in the presence of either
medium alone, or the vehicle (ethanol) or n-3 PUFA
throughout the migration assay. Finally, cells were fixed
with 3.7% paraformaldehyde (for 15 minutes), permeabi-
lized with 0.5% Triton-X-100 (for 3 minutes), blocked
with 1% bovine serum albumin (for 60 minutes), stained
with FITC-phalloidin and examined by fluorescence
m i c r o s c o p y .T oq u a n t i f ym i g r a t i o n ,t h ew i d t ho ft h e
wound was measured using the NIH Image software
(version 1.63) [40]. Statistical analysis was performed by
Student’s T-test, two tailed distribution, two-sample
unequal variance.
Immunofluorescence microscopy
For the analysis of non-contacting cells, cells were seeded
onto fibronectin-coated glass cover slips, allowed to
adhere for 120 minutes and then incubated with the indi-
cated compound for additional 60 minutes. Cells were
then treated as above and stained with primary and
TRITC-labeled secondary antibodies, as described [41].
Cover slips were mounted in 488-Mowiol and analyzed
with a Zeiss Axiophot microscope (equipped with 100X
Plan-Neofluar Ph3 objective lens). A similar protocol was
used for analyzing migrating cells at the wound edge.
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